“All symptoms in the 10 patients, especially fever, cough, shortness of breath, and chest pain, disappeared or largely improved within 1 [day] to 3 [days] upon CP transfusion,” said the study, published in a respected journal called the Proceedings of the National Academies of Sciences.
The study was conducted in Wuhan, China – where the coronavirus emerged in December – and was led by Kai Duan of China’s National Biotec Group Co. Ltd.
Read Our Latest News
Do you like this post?
Be the first to comment
Sign in with